Clinical curative effect analysis of gefitinib for treat NSCLC
- Received Date: 2007-09-05
Abstract: Objective :To analyze clinical curative effect of Gefitinib to treat NSCLC(non-small cell lung cancer). Methods :40 cases in-patient with NSCLC in Hospital of PLA General Hospital during Juan 2005 to Dec 2006,were administrated Gefitinib 250 mg daily orally,and investigated for it's curative effect. Results :The total effective rate was 35.0%,CR(complete remission)1 case,PR(partial remission) 13 cases,the disease control rate was 82.5%(CR was 1 case,PR was 13 cases,basio-stabilization was 19 cases).There were 29 male patients and 11 females,and effective rate were 55.2% and 36.4% respectively(P<0.05).The main adverse reaction were nausea and vomiting(37%),anorexy(25%),and exanthem(18%). Conclusion : Gefitinib has a better curative effect to treat NSCLC,and the adverse effect is gently,it can improve majority patient quality of life and survival.
Citation: | JIA Guo-qiang, YANG Ya-qing. Clinical curative effect analysis of gefitinib for treat NSCLC[J]. Journal of Pharmaceutical Practice and Service, 2007, (6): 399-400. |